Close
Close
Treatment Database
osimertinib
Trade Name Tagrisso
Orphan Indication Epidermal growth factor receptor mutation-positive non-small cell lung cancer
USA Market Approval 13-11-2015
USA Designation Date 04-09-2014
Sponsor AstraZeneca Pharmaceuticals LP
P. O. Box 8355, 1800 Concord Pike
Wilmington, Delaware, 19803
More about Non-small cell lung cancer
Free Newsletter
Related Videos
by Abidemi Uruejoma
599 views
by Abidemi Uruejoma
4,196 views
by Abidemi Uruejoma
9,958 views
by Dr. Jules Richard Kemadjou
10,155 views